Indrayani Biotech

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue16.1013.7719.2511.8210.40
Expenses15.7013.5117.6211.6510.27
EBITDA1.391.414.452.012.34
EBIT1.031.044.091.692.02
Profit Before Tax0.410.261.620.170.13
Net Profit0.410.260.070.130.10
Financial Ratios
Operating Profit Margin8.68%10.30%28.16%18.63%24.50%
Net Profit Margin2.56%1.90%0.44%1.20%1.05%
Earning Per Share (Diluted)0.110.060.080.030.02
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ